The study by Badie et al. (2008) has shown that a subgroup of breast cancer patients, who developed severe reactions to radiation therapy, could be identified by aberrant overexpression of CDKN1 in peripheral blood lymphocytes [43]. The gene discussed is CDKN1A; the disease is breast cancer.